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Abstract A recent analysis of leukaemia mortality in
Japanese A-bomb survivors has applied descriptive models,
collected together from previous studies, to derive a joint
excess relative risk estimate (ERR) by multi-model infer-
ence (MMI) (Walsh and Kaiser in Radiat Environ Biophys
50:21–35, 2011). The models use a linear-quadratic dose
response with differing dose effect modifiers. In the present
study, a set of more than 40 models has been submitted to a
rigorous statistical selection procedure which fosters the
parsimonious deployment of model parameters based on
pairwise likelihood ratio tests. Nested models were conse-
quently excluded from risk assessment. The set comprises
models of the excess absolute risk (EAR) and two types of
non-standard ERR models with sigmoidal responses or two
line spline functions with a changing slope at a break point.
Due to clearly higher values of the Akaike Information
Criterion, none of the EAR models has been selected, but
two non-standard ERR models qualified for MMI. The
preferred ERR model applies a purely quadratic dose
response which is slightly damped by an exponential factor
at high doses and modified by a power function for attained
age. Compared to the previous analysis, the present study
reports similar point estimates and confidence intervals (CI)
of the ERR from MMI for doses between 0.5 and 2.5 Sv.
However, at lower doses, the point estimates are markedly
reduced by factors between two and five, although the
reduction was not statistically significant. The 2.5 % per-
centiles of the ERR from the preferred quadratic-exponen-
tial model did not fall below zero risk in exposure scenarios
for children, adolescents and adults at very low doses down
to 10 mSv. Yet, MMI produced risk estimates with a
positive 2.5 % percentile only above doses of some
300 mSv. Compared to CI from a single model of choice,
CI from MMI are broadened in cohort strata with low sta-
tistical power by a combination of risk extrapolations from
several models. Reverting to MMI can relieve the dilemma
of needing to choose between models with largely different
consequences for risk assessment in public health.
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Introduction
In a recent analysis of leukaemia mortality in the Japanese
life span study (LSS) cohort of A-bomb survivors, a joint
radiation risk has been derived from a group of several
models by applying the technique of multi-model inference
(MMI) (Walsh and Kaiser 2011). Reduction of bias from
relying on a single model for risk assessment constitutes
the main virtue of MMI. Application of MMI can produce
more reliable point estimates and improves the character-
isation of uncertainties (Burnham and Anderson 2002).
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Walsh and Kaiser (2011) have chosen models for a so-
called group of Occam, after a review of the relevant lit-
erature in radio-epidemiology. The group contained those
models which were deemed adequate for joint risk infer-
ence (Hoeting et al. 1999; Kaiser et al. 2012). They were
then ranked according to the Akaike Information Criterion
(AIC) which penalises models with many parameters. A
joint risk estimate is given by the mean of model-specific
estimates with AIC-based weights, and confidence inter-
vals (CI) are calculated by approximate methods.
For the models discussed in Walsh and Kaiser (2011),
parameter parsimony was not always the main concern of
model authors so that highly parametrised models had
received negligible weights in the weighting process. This
intrinsic feature of MMI was criticised by Richardson and
Cole (2012). They argued that models with explanatory
variables which may have an impact on the radiation risk
are not considered adequately. In their reply, Walsh et al.
(2012) cautioned against the use of model parameters
which are not sufficiently supported by the data. Based on
the hypothetical problem posed by Richardson and Cole
(2012), Walsh et al. (2012) illustrated that models, which
contain parameters with weak statistical support, may
cause misleading point estimates of the risk. In other
examples, over-parametrised models may have little
impact on point estimates but can still inflate uncertainty
ranges artificially. This side-effect contorts risk assessment
in radiation protection if an accurate determination of
uncertainties is desired. Such desire is brought forward in
court cases related to compensation claims for detrimental
health effects from occupational radiation exposure (Niu
et al. 2010). For example, decisions in USA courts are
sometimes based on the 99 % CI of the probability of
causation for cancer in a specific organ (Kocher et al.
2008).
Thus, the criterion for the choice of models for MMI in
the study of Walsh and Kaiser (2011) has been changed
here, so that the advice of Walsh et al. (2012) is taken
seriously. Instead of picking models from peer-reviewed
literature without further qualifications, potential candidate
models are now submitted to a rigorous statistical selection
protocol. Such a protocol has been introduced by Kaiser
et al. (2012) and applied to the selection of both descriptive
and mechanistic breast cancer models for joint risk
inference.
All models considered in Walsh and Kaiser (2011)
include a linear-quadratic dose response with different
combinations of explanatory variables such as sex, age at
exposure and attained age to modify the dose response of
the risk. A linear-quadratic response is also preferred in the
LSS studies on leukaemia incidence (Preston et al. 1994)
and mortality (Preston et al. 2004). It is recommended by
committees BEIR VII (NRC 2006), ICRP (Valentin 2007)
and UNSCEAR (2008) after consideration of a sizeable
number of leukaemia risk studies.
Although the linear-quadratic response can be regarded
as the accepted standard in the radio-epidemiology of
leukaemia, a number of non-standard responses have been
tested motivated by earlier investigations. Little et al.
(1999) found that a quadratic-exponential response yielded
optimal fits when applied to LSS leukaemia incidence data.
Preston et al. (1994) applied a model of two linear dose
responses, represented by two line spline functions with a
changing slope at a break point, as an alternative to the
linear-quadratic response. Explicitly, nonlinear dose
responses with sigmoidal forms have also been investi-
gated. They are well-known in toxicology (Hodgson 2010)
and are applied in radiation biology to describe normal
tissue damage, i.e., of the skin (Hall 2006).
It is emphasised here that the choice of candidate
models is on no account exhaustive and that a possible
inclusion of non-standard models into Occam’s group is
mainly justified by goodness-of-fit criteria.
The assignment of weights to risk models is also prac-
tised to transport organ-specific risk estimates from the
LSS cohort to western populations, if no information on the
radiation risk in Caucasian cohorts is available. However,
committees BEIR VII (NRC 2006) and ICRP (Valentin
2007) support different approaches to combine an excess
absolute risk (EAR) model and an excess relative risk
(ERR) model with weights quantified by expert judgement.
In any case, adequate transfer models must provide a good
description of the risk in the population of origin. The
relevance of this statistical criterion for risk transfer con-
cerning leukaemia will be highlighted by the present study.
Past studies of the leukaemia risk at low doses for young
attained ages and ages at exposure were performed for
settlements in the vicinity of nuclear power stations (NPP)
(Laurier et al. 2008; Kaatsch et al. 2008) and to estimate
the proportion of cases induced by computer tomography
(CT) scans (Pearce et al. 2012) or natural background
radiation (Wakeford et al. 2009; Little et al. 2009; Kendall
et al. 2012). Investigations in these fields and, additionally,
ongoing risk assessment for residents near the Japanese
Fukushima Daiichi NPP may benefit from both risk esti-
mates with stronger support of the data and a more com-
prehensive quantification of uncertainties, which are the
aim of the present study.
Materials and methods
Epidemiological data set
The present study is closely related to the study of Walsh
and Kaiser (2011) which used LSS mortality data from
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1950 to 2000. After it appeared, the LSS data have been
updated with an extended follow-up to 2003 in Report 14
(Ozasa et al. 2012). To provide an analysis with the most
recent data set, all results reported by the present study are
based on LSS Report 14. The updated data set comprises
86,611 subjects, 318 leukaemia deaths (including 22 cases
in 2001–2003) and 3,294,282 person years (including
109,927 person years in 2001–2003). The person-year
weighted means are 22 year for age at exposure, 50 year
for attained age, 58 year for age of cases and 134 mSv for
the weighted dose to bone marrow with a factor of ten for
the relative biological effectiveness (RBE) of neutrons. The
RBE value depends on the radiation field and the detri-
mental health effect under observation. For leukaemia, an
estimation is difficult and produces very large CI (Little
1997; Hunter and Charles 2002). The LSS cohort data in
file lss14.csv are available for download from the website
of the Radiation Effects Research Foundation (RERF) in
Japan (http://www.rerf.or.jp).
The MECAN software package
The analysis has been performed with the MECAN soft-
ware package which is available from the corresponding
author by request (Kaiser 2010). A user manual, regression
control files and an executable to repeat the present anal-
ysis are included. MECAN is executed in a terminal on a
command line under Linux or Windows. To implement risk
models other than those applied here, a minimal knowledge
of the C?? programming language is required. The code
includes the C?? library MINUIT2 (Moneta and James
2010) from CERN which minimises the Poisson likelihood.
Pre-processing of the grouped data, regression, comparison
of observed and expected cases, and simulation of uncer-
tainty intervals can all be performed in one run. The cal-
culation of risk estimates from MMI is automated with
shell script files which contain the set of required
commands.
Results from MECAN for the preferred models of the
present study and of the study by Walsh and Kaiser (2011)
have been cross-checked by independent calculations with
the EPICURE package (Preston et al. 1993). Deviances
from the two packages differed by around 10-3 points.
Relative differences of estimates for model parameters,
Wald-type standard errors and CI from the likelihood
profile fell below 10-2. Relative differences in the entries
of the parameter correlation matrices exceeded one per cent
in some cases.
Baseline model
The model for the baseline mortality rates
h0ðs; c; a; eÞ ¼ expfb0 þ bss þ bcc
þ ba1 ln a=55ð Þ þ ba2 ln2 a=55ð Þ
þ be1 e  30ð Þ þ be2 e  30ð Þ2g
ð1Þ
applies the same functional form as the models of the
UNSCEAR committee and of Little et al. (2008) (see
Table 8 of Walsh and Kaiser 2011). The parameter b0
represents a constant factor, parameters bs and bc account
for rate differences by sex (males s = -1 and females
s = ?1) and city, i.e. Hiroshima (c = -1) and Nagasaki
(c = ?1). Parameters ba1 and ba2 quantify variations of
the rates with attained age. Parameters be1 and be2 depend
on age at exposure which for the acute exposure of the
A-bomb survivors serves as a surrogate for dependence on
birth cohort to account for secular trends in baseline rates.
The present baseline model consumes seven adjustable
parameters.
Model selection protocol
The selection protocol of Kaiser et al. (2012) has been
applied here. It starts with step-by-step attempts to optimise
the baseline model in Eq. (1) with exposure-related features
contained in a set of candidate models. Parameters are
added individually or in groups and retained, if the nested
model with the additional parameter(s) survived a likeli-
hood ratio test (LRT) against the model of origin. For
nested models, the difference between their deviances is
v2-distributed (Claeskens and Hjort 2008; Walsh 2007).
The number of degrees of freedom for the difference is
equal to the difference in the number of parameters. A
model with one additional parameter is considered an
improvement over the model without this parameter with a
95 % probability if the deviance is lowered by at least 3.84
points. The probability threshold is set relatively high to
avoid inclusion of spurious features in risk models
(Anderson et al. 2001; Walsh et al. 2012).
In the first round, various versions of the dose response
are tested which are shown schematically in the flow chart
of Fig. 1. To retain clarity, not all tested models are shown.
A second round would involve improvements with dose
effect modifications by explanatory variables such as sex,
age at exposure or attained age, an example is given in
Eq. (4). After passing an LRT, a model is kept for further
rounds of testing. It may join Occam’s group, if improve-
ments are no longer possible. Defeated models are rejected
for risk assessment. In Fig. 1, a defeated model is identified
by at least one arrow pointing away from it. Models sur-
viving the last round of tests ‘see’ only arrowheads. More
details of the protocol are given in Kaiser et al. (2012).
In the present analysis, an additional selection criterion
prevents the overpopulation of Occam’s group with models
Radiat Environ Biophys (2013) 52:17–27 19
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of negligible influence. Based on the Akaike Information
(Akaike 1973; Burnham and Anderson 2002)
AIC ¼ dev þ 2 Npar; ð2Þ
where dev denotes the Poisson deviance and Npar denotes the
number of parameters, a weight 1=½1 þ expðDAICk=2Þ
can be constructed for the pairwise comparison of the pre-
ferred model with AIC0 and model k with AICk, where
DAICk ¼ AICk  AIC0: If this weight fell below 5 % (or
DAICk exceeds 5.99), the corresponding model k was not
used for risk assessment (Hoeting et al. 1999; Walsh 2007).
Note, that the second criterion does not constitute a statistical
test (Burnham and Anderson 2002, p 84). After its applica-
tion, the L-exp model with dose effect modifier for attained
age has been discarded (see Fig. 1).
At the end of the selection procedure, Occam’s group of
non-nested risk models with enough relevance for risk
assessment has been established for use in the MMISP
analysis.1
Candidate models for Occam’s group
From the outset, the dose response of candidate models is
constrained to yield a zero excess risk at zero dose and to
rise monotonously with an increasing dose. Models with
hormetic dose responses have not been tested but would
have been admitted into Occam’s group if they qualified.
Apart from these preconditions, admission to Occam’s
group is achieved solely by sufficient goodness-of-fit.
Improvements of the baseline model from Eq. (1) have
been attempted with three types of dose responses ‘LQ-
exp’, ‘sigmoid’ and ‘spline’ (see Fig. 1) for both EAR and
ERR models. The complete dose response of the LQ-exp
model took the form (a d ? b d2)exp(-c d). To account
for random errors, the dose-squared covariable has been
multiplied with a factor of 1.12 (Walsh and Kaiser 2011;
Pierce et al. 1990). Sub-models with all seven possible
combinations of the dose–response parameters a, b and c
have been tested but only the two parameter combinations
a, b (sub-model LQ for linear-quadratic) and b, c (sub-
model Q-exp for quadratic-exponential) survived the series
of LRTs. Cubic-exponential or quadratic-exponential
models did not yield better fits than the Q-exp model. But a
model with a sigmoidal response (which progresses from
small beginnings and levels off at high doses) and a model
with two linear dose responses, connected by a break point
at dose dk (termed spline model), could also be added to
Occam’s group.
To perform valid LRTs, two continuous derivatives
(i.e. a C2 condition) of the Poisson deviance with respect
to the model parameters are required (Schervish 1997).
All but one model apply parametric functions which are
twice continuously differentiable. For the spline model, it
is not obvious that the C2 condition is fullfilled for
derivatives with respect to the break point dk. Therefore,
the region around the minimum of the Poisson likelihood
as a function of dk has been scanned numerically by
fixing dk at different values and re-fitting the remaining
parameters. The scan revealed a slightly tilted paraboloid
so that both derivatives are indeed continuous. The min-
imum is reached at dk = 0.36Sv (r CILP 0.28; 0.52). The


















Fig. 1 Flow chart of model selection. Models are grouped in rows
pertaining to equal number of model parameters Npar. The protocol
starts with the baseline model bsl (top), arrows point to models which
survived a pairwise LRT on the 95 % level. Dose effect modifiers are
annotated as e for age at exposure and as a for attained age. AIC
differences to the preferred model Q-exp with dose effect modifier for
a are given for all models surviving the last round of tests. Model
L-exp with dose effect modifier for a is discarded because its DAIC
exceeded 5.99 (dashed arrow line)
1 The present study is named MMISP study, since models are chosen
by a Selection Protocol. For a better distinction, the study of Walsh
and Kaiser (2011) is named here MMIPM study, since it was based on
previously Published Models.
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MINOS routine of MINUIT2. A graphical evaluation of
the numerical scan yielded the same values.
Dose effect modifiers of sex s, age at exposure e and
attained age a have been tested separately and in combi-




in all three types of dose responses shown in Fig. 1. The
difference between males and females was not significant
for all selected ERR models in contrast to the results of the
(discarded) EAR models.
Determination of model-specific risk estimates
and confidence intervals
A best risk estimate for a single model is calculated with
the set of parameter estimates which minimises the likeli-
hood. To determine the corresponding CI, a probability
density function (pdf) with 10,000 entries is generated by
Monte-Carlo simulation which accounts for uncertainty
ranges and pairwise correlations of all adjusted parameters.
Two percentiles, corresponding to the required level of
confidence (i.e. 95 %), are adopted as upper and lower CI.
To meet the requirement of a symmetric parameter
correlation matrix as the backbone of the Monte-Carlo
simulation, each parameter-specific pdf must ideally follow
a Gaussian distribution. As a necessary precondition, the r
CILP, calculated from the likelihood profile, should lie
symmetrically around the best parameter estimate. The
precondition is fullfilled for the baseline model given in
Eq. (1) which is used by the models of Occam’s group. All
parameters of the ERR in the LQ and the Q-exp model
show symmetric CILP to a good approximation if models
are centred at e = 30 and a = 55 (see Table 1). However,
models centred at young ages at exposure and attained ages
exhibit markedly skewed CILP for the linear and the qua-
dratic term in the ERR(d). The ERR parameters a and b of
the sigmoid model possess asymmetric CILP with ratios of
0.7 and 2 between lower and upper bound but the asym-
metry did not disappear for centring at different values.
The spline model had symmetric CILP for the two linear
risk coefficients but the break point dk showed asymmetric
CILP for all tested combinations of centring. To calculate
CI with Monte-Carlo simulation for all five combinations
of e and a, the models have been centred at e = 30 and
a = 55. Although the precondition of symmetric parameter
CILP is not fully met for two ERR parameters of the sig-
moid model and one parameter of the spline model, one
expects that Monte–Carlo simulations of uncertainties for
these two models yield results with a moderate bias.
Centring does not change the quality of fit, i.e., the value
of the Poisson deviance and the best risk estimates. Walsh
and Kaiser (2011) exploited this fact and centred the risk
models at seven pairs of a and e for a more convenient
calculation of uncertainties. Especially at young ages, their
approach (implemented in their Method 1) yielded sym-
metric CI in the Monte-Carlo simulations even if the correct
CILP from the profile likelihood were highly asymmetric.
To partly make up for this bias, the simulation of CI in their
MMIPM analysis has been repeated with their models cen-
tred at e = 30 and a = 55 with approx. symmetric CILP.
Moreover, the complete parameter correlation matrix was
used now to simulate parameter uncertainties instead of the
fraction that pertained to the ERR part of the model. In the
repeated analysis, only the four models with the highest
weights (see Table 3 of Walsh and Kaiser (2011)) were
applied to the data set of LSS report 14 (Ozasa et al. 2012).
Now the 2.5 % percentiles of the ERR for the UNSCEAR
model do not drop below zero in contrast to the results
reported in Table 4 of Walsh and Kaiser (2011).
Multi-model inference
The surviving models are ranked according to their AIC,







j¼0 expð 12 DAICjÞ
ð3Þ
has been assigned.
The central risk estimate from MMI is given by the AIC-
weighted mean of best estimates from the models in
Occam’s group. The CI of the MMI mean are derived from
a joint pdf with 10,000 entries which is obtained by merging
the model-specific pdf with sizes corresponding to the AIC-
weight (i.e. 5,301, 2,062, 1,927 and 710 realisations from
models Q-exp, sigmoid, spline and LQ, see Table 2). From
the joint pdf, an approximation of the unconditional sam-
pling variance [see Burnham and Anderson 2002, Eq. (4.3)]
Table 1 Best parameter estimates, symmetric Wald-type DCI from a
parabolic approximation around the minimum of the likelihood
function, and DCILP from the actual likelihood profile for the pre-
ferred Q-exp model; to facilitate the assessment of symmetry, DCIare
given as distances from the best parameter estimate in the standard r
range
Name Unit Best estim. Wald-type DCI DCILP
b0 – -9.50 0.10 -0.11; 0.10
bs – -0.322 0.057 -0.057; 0.057
bc – -0.140 0.065 -0.066; 0.064
ba1 – 2.11 0.27 -0.27; 0.27
ba2 – 1.08 0.21 -0.21; 0.20
be1 10
-3 year-1 6.4 -0.46 -0.46; 0.46
be2 10
-4 year-2 -7.2 2.3 -2.3; 2.2
b Sv-2 4.3 1.2 -1.1; 1.4
c Sv-1 -0.38 0.13 -0.13; 0.13
 – -1.62 0.35 -0.36; 0.34
Radiat Environ Biophys (2013) 52:17–27 21
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can be obtained. Implicitly, this pdf also accounts for model
correlations.
Results
For a total of 26 ERR and 16 EAR candidate models, lists
of Poisson deviances, number of parameters and AIC val-
ues are given in the online resource as a PDF excerpt of an
EXCEL workbook (ESM1). The AIC of the preferred EAR
model was still about 11 points away from the AIC of the
preferred ERR model. Thus, no EAR model fell within
Occam’s group.
For the four selected models, files with model-specific
data on the quality of fit, parameter estimates and CI (from
both the parabolic approximation of the likelihood mini-
mum and from the likelihood profile), the parameter cor-
relation matrix and tables to compare observed and
expected cases are added to the online resource in PDF
format. The data provided allow a repetition of the MMISP
analysis without re-fitting the corresponding models.
Table 2 presents the four ERR models in Occam’s
group. Only the dose dependence ERR(d) is shown there,
the final form




additionally applies a power function for attained age
a centred at 55 year.
Compared to the previous analysis, the baseline function
of both the LQ model and LQ-exp model from Schneider and
Walsh (2009) was replaced by Eq. (1) with one parameter
less which increased the deviance by only about one point.
Accounting for the explanatory variables of sex and age at
exposure yielded no significant improvements of their
models so they were discarded. With these modifications, the
LQ model of Schneider and Walsh (2009) morphed into the
LQ model of the present analysis, which is equivalent to
the UNSCEAR model considered in Walsh and Kaiser
(2011). With the same modifications, and after elimination
of the linear term, the LQ-exp model of Schneider and Walsh
(2009) became the preferred Q-exp model of the present
analysis with parameter estimates given in Table 1. The
model of Little et al. (2008) was excluded from Occam’s
group because the dependence on age at exposure did not
survive the LRT with the UNSCEAR model.
The UNSCEAR model (termed LQ model in the present
analysis) dominated the MMIPM risk estimate in Walsh and
Kaiser (2011) with a weight of 51 % (see their Table 5),
but here its contribution is reduced to only 7 %. Now the
Q-exp model is preferred with a weight of 53 % with a four
points lower deviance than the LQ model. Inspection of
tables, which compare observed and expected cases in
model-specific result files (here ESM3 and ESM2) of the
online resource, suggests that the Q-exp model produced
slightly better fits to the data at young ages of exposure and
attained ages. For example, for Poisson strata (numbered 0,
10, 20 in the result files) with person-year weighted means
of e ^ 5 year, a ^ 15 y the contribution to the Poisson
deviance of the Q-exp model is about 2.5 points lower
compared to the LQ model. Such exposure scenarios are
of enhanced interest for radiation protection and here
the Q-exp model yields lower (and better supported)
risk estimates than models with a linear-quadratic dose
response.
The quadratic term of the Q-exp model determines the
response at doses \0.5 Sv, damping by the exponential
term becomes important above [2.5 Sv. In the intermedi-
ate range between 0.5 and 2.5 Sv, the response is well
approximated by a linear relationship (see Fig. 2). Between
2.5 and 3 Sv, nine cases have been recorded and there are
only two cases above 3 Sv. The markedly different risk
estimates for high doses are caused by the low statistical
power in the corresponding cohort strata.
Table 2 Parametric dose dependence for the ERR models of




Form of ERR(d) Npar Deviance AIC-
Weight
Q-exp bd2 expðcdÞ 10 2,670.890 0.5301
Sigmoid A
BþdC 11 2,670.778 0.2062
Spline a1d for d\dk
a2ðd  dkÞ for d  dk

11 2,670.914 0.1927
LQ a d ? b d2 10 2,674.910 0.0710
0 1 2 3 4




















MMIPM (Kaiser & Walsh 2011)
Fig. 2 Excess relative risk (AIC-weighted mean or best estimate for
separate models, with 95 % CI) for a 55-year old adult exposed at age
30 from MMISP (present analysis), the preferred Q-exp model, the
sigmoid model, the spline model, the LQ model and from the repeated
MMIPM analysis with the four top-ranking models of Walsh and
Kaiser (2011)
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The ERR at low doses for a 7-year-old child exposed at
age 2 is shown in Fig. 3. Compared to the previous anal-
ysis, the AIC-weighted mean of the ERR from MMISP is
reduced, i.e.,. by a factor of two at 100 mSv, although the
reduction is not statistically significant. The effect of any
one model is directly visible in the MMI dose response if it
has a weight of more than fifty per cent. The AIC-weighted
mean from MMISP closely follows the best estimate of the
preferred Q-exp model. The additional three models cause
a sizeable increase of the CI especially at low doses where
a determination of the ERR implies an extrapolation to
cohort strata with almost no cases (see Table 2 of Walsh
and Kaiser 2011). In these regions, CI from a single model
of choice underestimate the risk uncertainty by wide mar-
gins (see also Tables 3, 4).
Tables 3, 4 and 5 present the ERR from the four models of
Occam’s group separately and from MMISP of the present
analysis and of the MMIPM analysis by Walsh and Kaiser
(2011) at 10 mSv, 100 mSv and 1 Sv. At exposure of 1 Sv,
both MMI analyses and all separate models yield similar
estimates and CI for children, adolescents and adults.
The situation changes at 100 mSv. Now the new pre-
ferred Q-exp model predicts a four times lower risk than
the previously chosen UNSCEAR (here LQ) model.
Compared to the repeated MMIPM analysis with the four
top-ranking models of Walsh and Kaiser (2011), estimates
from the present MMISP analysis differ by a factor of 2.5
and the CI are markedly reduced.
At 10 mSv, the AIC-weighted mean of the present study
no longer approximates the best estimate of the preferred
Q-exp model. The mean is strongly influenced by a 30
times higher estimate of the LQ model which on the other
hand acquires the lowest weight in MMISP. To avoid this
effect and to preserve the similarity between the point
estimates from the preferred model and from MMI, Kaiser
et al. (2012) recommend to replace the AIC-weighted
mean by the median of the joint pdf, which is given in
brackets in Table 3.
At doses of 10 mSv and 100 mSv, the 2.5 % percentiles
from the present MMISP analysis include a zero risk due to
the uncertainty of the spline model.
0 0.1 0.2 0.3



















MMIPM (Walsh & Kaiser 2011)
Fig. 3 Excess relative risk (AIC-weighted mean or best estimate for
model Q-exp, with 95 % CI) for a 7-year old child exposed at age 2
from MMISP (present analysis), the preferred Q-exp model and from
the repeated MMIPM analysis with the four top-ranking models of
Walsh and Kaiser (2011)
Table 3 ERR (10-2) at 10 mSv
for five combinations of age at
exposure e and attained age a
AIC-weighted mean for MMI or
model-specific best estimate in
first row, 95 % CI from Monte-
Carlo simulation in second row,
for MMISP the mean is
calculated with the model-
specific weights of Table 2
y median of joint pdf from
MMISP in brackets
 Point estimates and CI from













MMIPM 33.5 13.7 7.80 5.12 1.14
Walsh and
Kaiser (2011)*
-33.5; 208 -12.4; 61.7 -7.24; 28.5 -4.78; 16.4 -1.22; 2.77
LQ 40.4 16.8 9.48 6.22 1.39
UNSCEAR
(2008)
-0.753; 215 -0.370; 64.0 -0.237; 29.2 -0.167; 16.5 -0.0402; 2.80
Spline 17.7 7.34 4.15 2.72 0.609
-36.3; 153 -12.9; 46.1 -6.98; 22.0 -4.36; 12.8 -1.00; 2.19











Q-exp 1.20 0.501 0.285 0.188 0.0427
(preferred
model)




7.09 (1.41) 2.94 (0.568) 1.67 (0.317) 1.09 (0.206) 0.245 (0.0463)
(present study) -9.02; 92.7 -3.67; 31.8 -2.01; 16.3 -1.34; 9.89 -0.323; 1.99
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Discussion
Little et al. (1999) analysed the dose response for three
subtypes of acute myeloid leukaemia (AML), chronic
myeloid leukaemia (CML) and acute lymphocytic leukae-
mia (ALL) separately and for all subtypes combined. Their
analysis was carried out with LSS incidence data, and with
two other data sets of women treated for cervical cancer
(incidence) and UK patients treated for ankylosing
spondilitis (mortality). From a list of 13 ERR models, using
similar versions of the general LQ-exp response with dose
effect modifiers, the Q-exp response has been preferred for
yielding the optimal fit. They used already LRTs to discard
models with statistically insignificant features. Their esti-
mates of the coefficients b for the dose squared and c for the
exponential damping were 5.8 (95 % CI 2.7; 11) Sv-2 and
-0.49 (95 % CI -0.76; -0.22) Sv-1, respectively (see
their Table 5). Risk estimates for leukaemia incidence are
expected to exceed those for mortality. Comparison with
estimates in Table 1 shows that this relation is realised for
dose . 3 Sv, albeit without statistical significance.
Separate estimates for the other two data sets produced
no significant risk (women with cervical cancer) or a ten
times larger coefficient b (patients with ankylosing
spondilitis). Comparison of risks in these different popula-
tions is complicated by the consideration that the LSS
subjects were not under observation because of known
diseases whereas members of the two other data sets were.
Basic tenets of MMI might be extended to address
questions of risk transfer between populations which are
discussed in reports of committees BEIR VII (NRC 2006)
and ICRP (Valentin 2007). BEIR VII propose to transfer
risks for solid cancer sites (except breast and thyroid) and
for leukaemia from the LSS cohort to the US population
with a linear combination of an ERR model and an EAR
model. They recommend point estimates as weighted means
obtained under the two models. For leukaemia and solid
cancer sites (except breast, thyroid and lung), the weights of
Table 5 ERR at 1 Sv for five
combinations of age at exposure
e and attained age a
AIC-weighted mean for MMI or
model-specific best estimate in
first row, 95 % CI from Monte-
Carlo simulation in second row,
for MMISP the mean is
calculated with the model-
specific weights of Table 2
* Point estimates and CI from













MMIPM 81.8 32.9 18.7 12.3 2.76
Walsh and Kaiser (2011)* 17.0; 356 10.2; 97.7 6.24; 44.2 5.28; 24.9 1.60; 3.90
LQ 78.6 32.6 18.4 12.1 2.71
UNSCEAR (2008) 17.2; 348 10.2; 100 7.16; 44.9 5.48; 24.8 1.59; 3.81
Spline 101 42.0 23.8 15.6 3.49
22.8; 423 13.8; 121 9.83; 54.2 7.60; 30.1 2.27; 4.69
Sigmoid 91.1 38.3 21.9 14.5 3.31
18.7; 345 10.9; 102 7.61; 46.5 5.77; 26.3 1.56; 4.37
Q-exp (preferred model) 82.4 34.4 19.6 12.9 2.94
(preferred model) 18.2; 322 10.8; 94.4 7.45; 43.1 5.55; 24.3 1.54; 3.91
MMISP (present study) 87.6 36.6 20.8 13.7 3.10
(present study) 19.7; 343 11.4; 101 7.95; 46.2 5.94; 25.9 1.60; 4.31
Table 4 ERR (10-1) at
100 mSv for five combinations
of age at exposure e and
attained age a
AIC-weighted mean for MMI or
model-specific best estimate in
first row, 95 % CI from Monte-
Carlo simulation in second row,
for MMISP the mean is
calculated with the model-
specific weights of Table 2
* Point estimates and CI from













MMIPM 38.5 15.7 8.92 5.86 1.31
Walsh and Kaiser (2011)* -15.5; 219 -6.19; 64.7 -3.61; 29.8 -2.49; 17.0 -0.642; 2.84
LQ 43.9 18.2 10.3 6.76 1.51
UNSCEAR (2008) 2.37; 227 1.18; 66.5 0.745; 30.3 0.513; 17.2 0.125; 2.88
Spline 17.7 7.34 4.15 2.72 0.609
-36.3; 153 -12.9; 46.1 -6.98; 22.0 -4.36; 12.8 -1.00; 2.19
Sigmoid 9.58 4.03 2.30 1.52 0.348
0.298; 91.9 0.145; 31.4 0.0889; 15.7 0.0620; 9.56 0.0164; 1.89
Q-exp (preferred model) 11.6 4.84 2.76 1.82 0.413
(preferred model) 2.39; 48.2 1.37; 14.4 0.932; 6.67 0.683; 3.79 0.182; 0.633
MMISP 14.6 6.10 3.47 2.28 0.515
(present study) -8.60; 103 -3.58; 34.0 -1.97; 17.6 -1.31; 10.5 -0.312; 2.07
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0.7 (ERR) and 0.3 (EAR) are chosen by expert judgement
based on the observation ‘that there is a somewhat greater
support for relative risk than for absolute risk transport’ (see
p. 276). Inconsistent with BEIR VII, ICRP recommend to
apply only the EAR model of Preston et al. (1994) for
leukaemia incidence.
In general, the consensus on a risk transfer model is based
on a complex mix of factors, but a comprehensive consid-
eration is beyond the scope of the present study. However,
any adequate transfer model should provide a good
description of the risk in the population of origin. Would
goodness-of-fit criteria be allowed to assess the adequacy of
a model, EAR models of leukaemia mortality would not
contribute to the transfer. The best EAR model exceeds the
AIC of the preferred Q-exp model by about 11 points which
leads to a negligible AIC-weight. A second criterion of
Bayesian information ðBIC ¼ dev þ Npar lnðncasesÞÞ is often
used as an alternative to the AIC because it favours more
parsimonious models (Claeskens and Hjort 2008). It is 18
points higher which constitutes strong evidence (Kass and
Raftery 1995) for the rejection of the EAR model. Likewise,
Little (2008) recommends to drop EAR models, but with a
different rationale. Based on a comparison of risks for
childhood exposure between the LSS cohort and three
medically exposed groups in Europe, he observed that het-
erogeneity in cohort-specific EAR estimates is much higher
than in ERR estimates.
A recent risk study of leukaemia (and brain tumours)
after childhood exposure by CT scans reports an ERR of 36
(95 % CI 5; 120) Sv-1 from a purely linear model for age at
exposure\22 year, dose range between 0 and 100 mSv and
follow-up of 23 year (Pearce et al. 2012). The same linear
model applied to the LSS incidence data (Preston et al.
1994) produced an ERR of 37 (95 % CI 14; 127) Sv-1 for
age at exposure \20 year, dose range between 0 and 4 Sv
and follow-up of 20 year (see Table 8 of the supplement to
Pearce et al. (2012)).
The authors of the present study fitted a purely qua-
dratic model to the LSS incidence data for all dose ranges
which increased the deviance by 4.8 points compared to
the linear model. If the overlap of dose ranges was
improved by a reduction to 0–500 mSv for the LSS data,
the quadratic model yielded a slightly better fit. The
deviance decreased by 2.4 points compared to the linear
model. Improved fits of a quadratic model at lower doses
are in line with findings of the present study (mortality)
and the study of Little et al. (1999) (incidence). With a
coefficient of 61 (95 % CI 22; 185) Sv-2 for the quadratic
model, the ERR at 100 mSv is six times lower than for the
linear model. Using both models in MMI would still yield
a reduction of the ERR by a factor of three compared to
the linear model.
Nevertheless, Pearce et al. (2012) report ‘little evidence
of nonlinearity of the dose response, using either linear-
quadratic or linear-exponential forms of departure from
linearity’, but purely quadratic responses appear not to
have been tested. At this point, the present authors suggest
a comparison of the CT risk with the LSS quadratic
response. Should alternative dose responses, such as purely
quadratic, fit the data comparably well, an even fairer
comparison might account for model uncertainty in the CT
cohort. In this case, reverting to MMI can relieve the
dilemma of needing to choose between models with largely
different consequences for issues of public health, e.g., for
assessing the risk-to-benefit ratio related to a CT scan. In a
wider context, MMI might be of use for statistical analysis
in a number of cohort studies of CT exposure and cancer
incidence which will be completed in the near future
(Einstein 2012).
Conclusions
Only models with a linear-quadratic dose response were
included in the MMI analysis of Walsh and Kaiser (2011).
The present analysis introduced three models with non-
standard dose responses which produced significantly bet-
ter fits to the data. All considered models yield very similar
point estimates and uncertainties in the dose range
0.5–2.5 Sv, i.e., in cohort strata with a sufficient number of
cases. Divergent predictions appear in strata with almost no
cases for children and adolescents exposed to very low
doses of 100 mSv and below (see Table 2 of Walsh and
Kaiser 2011). Yet for purposes of radiation protection,
these exposure scenarios are of increased interest. Com-
pared to the study of Walsh and Kaiser (2011), the present
MMI analysis predicts markedly lower risks with factors of
two around 100 mSv and up to five for lower doses. These
point estimates are considered as more reliable since they
were produced with models, which describe the data
slightly better notably for children and adolescents.
Besides the improvement of point estimates, a second
benefit of MMI has been demonstrated. Several plausible
models can be included in a more comprehensive (though
not exhaustive) determination of uncertainties. Again, the
benefit becomes noticeable in the above-mentioned cohort
strata with low statistical power, where the risk is deter-
mined by extrapolation. Now uncertainty ranges are mainly
determined by the spread of model-specific point esti-
mates, whereas the model-specific uncertainty ranges are
rather small. Hence, inferring uncertainties from a single
model of choice may lead to a substantial underestimation.
In this context, the present MMI study provides significant
risks only above some three hundred mSv, whereas the
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95 % CI of the preferred Q-exp model do not include a
zero risk for all considered exposure scenarios.
The impact of pertinent sources of uncertainty, such
as the ‘healthy survivor effect’, errors in dosimetry or
misdiagnosis of cases on risk estimates has been discussed
extensively in the literature, for the LSS cohort see, e.g.,
Little et al. (1999), Preston et al. (2003), Preston et al.
(2004). Already Little et al. (1999) preferred ERR models
with a Q-exp response. They did, however, not consider the
additional contribution to the uncertainty which is induced
by including models with other plausible dose responses
into the risk analysis. In this developing field of research in
radiation epidemiology, the present MMI study aims to be
of help.
The model selection bias cannot be eliminated by MMI
but can be markedly reduced. The bias is transferred from
the level of picking a single model of choice to picking a set
of candidate models. In the present analysis, this set inclu-
ded more than 40 models with different forms of dose
responses, of which four models have been admitted to
Occam’s group. Under the given rules for model selection, it
appears unlikely that by broadening the basis of candidate
models a considerable number of new models would enter
Occam’s group. Even if new models appeared, their impact
on risk estimates would be contained by the original models.
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